News

Risk factors and outcomes of high-impact chronic pain (HICP), ie, chronic pain (CP) and substantial restriction of participation in work, social, or self-care…

The funding is tied to a federal model designed to help Medicaid programs pay for expensive cell and gene therapies. It would help cover treatment for patients on…

In a recent announcement, the U.S. Food and Drug Administration (FDA) approved the first gene therapy for children aged 2 years and older with sickle cell disease.…

Dang. More than six hundred and fifty suspected sickle cell anemia patients have been found when more than five thousand citizens were tested for sickle cell anemia…

Hydroxyurea monotherapy is insufficient to treat chronic anemia in sickle cell disease (SCD); rather, a combination therapy approach is likely to yield more…

AbstractSickle cell disease (SCD) and thalassemia are genetic disorders that necessitate accurate diagnosis for effective management and improved patient outcomes.…

The US Food and Drug Administration (FDA) has accepted Agios Pharmaceuticals, Inc.’s supplemental New Drug Application (sNDA) for mitapivat in sickle cell disease (…

The Sickle Cell Anemia Testing and Screening Market offers growth opportunities through expanded newborn testing, molecular diagnostics, and digital workflows.…

Ugandans have been urged to know their sickle cell status and embrace early screening as the country strengthens efforts to combat sickle cell disease, one of the…

In developed countries, many people living with sickle cell disease routinely celebrate their 50th, 60th birthdays and beyond, enjoying good quality of life thanks…